title: Successful cord blood transplantation for an HIV-negative patient with refractory plasmablastic lymphoma.
authors.affiliation: Department of Hematology, Osaka Red Cross Hospital, 5-30 Fudegasakicho, Tennoji-ku, Osaka, 543-8555, Japan. second24@kuhp.kyoto-u.ac.jp.|Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, 54 Kawaharacho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan. second24@kuhp.kyoto-u.ac.jp.
authors.forename: Katsuyuki
authors.initials: K
authors.lastname: Nishi
authors.affiliation: Department of Hematology, Osaka Red Cross Hospital, 5-30 Fudegasakicho, Tennoji-ku, Osaka, 543-8555, Japan.
authors.forename: Sachiko
authors.initials: S
authors.lastname: Mitani
authors.affiliation: Department of Hematology, Osaka Red Cross Hospital, 5-30 Fudegasakicho, Tennoji-ku, Osaka, 543-8555, Japan.
authors.forename: Kazuo
authors.initials: K
authors.lastname: Hatanaka
authors.affiliation: Department of Hematology, Osaka Red Cross Hospital, 5-30 Fudegasakicho, Tennoji-ku, Osaka, 543-8555, Japan.
authors.forename: Kazunori
authors.initials: K
authors.lastname: Imada
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D036101:Cord Blood Stem Cell Transplantation; D004351:Drug Resistance; D019008:Drug Resistance, Neoplasm; D020031:Epstein-Barr Virus Infections; D005260:Female; D018023:HIV Seronegativity; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D008180:Lupus Erythematosus, Systemic / Q000150:complications / Q000188:drug therapy; D000069293:Plasmablastic Lymphoma / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000628:therapy* / Q000821:virology; D012074:Remission Induction; D019172:Transplantation Conditioning / Q000379:methods
chemical_list: D007166:Immunosuppressive Agents